ADAM10 Was Upregulated and Positively Correlated With NLGN3 and LYN Expression in Glioma, ADAM10 Inhibitor Suppressed the Migration and Invasion of Glioma Cells. This evidence concerns the gene ADAM10 and central nervous system cancer.